• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    International journal of mycobacteriology

    International journal of mycobacteriology

    JournalISSN 2212-5531eISSN 2212-554X中科院 医学 4区

    年发文量

    研究主题

    论文(1459)

    排序
    1Outcomes of Pulmonary Tuberculoma Following Standard Antituberculosis Therapy: an Observational Study
    Elisna Syahruddin, Andre Thadeo Abraham,Heidy Agustin,Sita Laksmi Andarini,Jamal Zaini,Fathiyah Isbaniah, Ginanjar Arum Desianti, Hario Baskoro

    Background: Tuberculosis (TB) in Indonesia causes a high burden, with pulmonary tuberculoma representing a mass-like manifestation that poses diagnostic and therapeutic challenges due to poor drug penetration. Data regarding the treatment duration and outcomes of pulmonary tuberculoma remain limited. This study aims to evaluate characteristics and outcomes of pulmonary tuberculoma following standard anti-TB therapy in Indonesia. Methods: This retrospective study evaluated pulmonary tuberculoma confirmed with histopathological findings of granulomatous inflammation at the National Respiratory Center in Indonesia, between 2022 and 2025. Enrolled subjects had completed anti-TB therapy. Clinical and radiological outcomes were evaluated upon treatment completion. Tuberculoma size was measured as the longest diameter on a computed tomography scan. Radiological response was categorized as complete resolution, decreased (≥30% reduction), increased (≥20% increase), or stable (the remainder). Results: A total of 38 subjects were analyzed. The most common radiological characteristic was multiple, irregular lesions, with a median size of 4.4 cm (range: 1.4–10.1 cm). The median treatment duration was 12 months (range: 6–18 months). All subjects achieved clinical improvement, while sequelae were reported in 5 (13.2%) subjects. Radiological evaluation showed complete resolution in 9 (23.7%) subjects, decreased in 15 (39.5%), and stable in 14 (36.8%). Bivariate analysis revealed that positive microbiological status was significantly associated with lower odds of complete resolution (odds ratio = 0.17, 95% confidence interval: 0.03–0.85, P = 0.036). A single tuberculoma was also associated with complete resolution, while none of the patients with multiple tuberculomas achieved complete resolution ( P = 0.014). Multivariate analysis was not performed due to the limited number of events. Conclusions: The treatment duration for pulmonary tuberculoma varies from 6 to 18 months, with nearly two-thirds of patients achieving radiological improvement. Positive microbiological status and multiple lesions are significant factors associated with incomplete radiological resolution.

    2026
    引用
    AI阅读
    加入学术空间
    2Survival-based Prognostic Factors for Mortality in Drug-resistant Tuberculosis: A Systematic Review and Meta-analysis
    Ahmad Zhafir Zulkifli,Nurhuda Ismail,Siti Munira Yasin, Tajul Rosli Razak,Mohamad Rodi Isa

    Mortality among patients with drug-resistant tuberculosis (DR-TB) remains substantial despite advances in diagnosis and treatment. Individual studies have reported multiple prognostic factors for death, but findings remain heterogeneous. The objective of this study is to systematically review and quantitatively synthesize evidence on prognostic factors associated with mortality among patients with DR-TB using hazard ratios (HR) derived from survival analyses. A systematic search of PubMed, Scopus, and Web of Science was conducted to retrieve articles published from database inception to the final search date on March 31, 2026. Observational longitudinal studies involving patients with any form of DR-TB were included if they reported adjusted HR for all-cause mortality from survival models. Study selection followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 guideline. Risk of bias was assessed using the Quality in Prognosis Studies tool. Fixed-effects and random-effects meta-analyses using restricted maximum likelihood were performed for prognostic factors reported in at least three comparable studies, whereas other factors were synthesized narratively. The study protocol was registered in the International Prospective Register of Systematic Reviews (PROSPERO) ID: CRD420261355163. A total of 34 studies published between 2006 and 2025 were included in the study. Most studies were retrospective cohort studies conducted mainly in Asia and Africa. The pooled analysis demonstrated that several factors were significantly associated with increased mortality including human immunodeficiency virus infection (pooled HR = 2.40; 95% confidence interval [CI] 1.73, 3.33), smoking (pooled HR = 2.07; 95% CI 1.48, 2.90), anemia (pooled HR = 1.79; 95% CI 1.51, 2.12), low body mass index or underweight (pooled HR = 2.08; 95% CI 1.69, 2.56), and diabetes mellitus (pooled HR = 1.77; 95% CI 1.29, 2.44). Gender was not significantly associated with mortality (pooled HR = 0.92; 95% CI 0.77, 1.11). Between-study heterogeneity ranged from low to substantial across the meta-analyses. Age, bacteriological positivity, previous TB treatment history, and drug resistance classification were synthesized narratively because of substantial heterogeneity in exposure definitions and comparator groups across studies. Mortality in DR-TB appears more consistently associated with clinical vulnerability and comorbidity rather than demographic characteristics or resistance profile alone. These findings support a risk-based approach to DR-TB care including early identification of high-risk patients, nutritional and comorbidity assessment and closer treatment monitoring.

    2026
    引用
    AI阅读
    加入学术空间
    3Differential Expression and Correlation of High-mobility Group Box 1 and Vascular Endothelial Growth Factor Messenger Ribonucleic Acid Across Leprosy Clinical Groups and Healthy Controls: A Cross-sectional Study
    Rizki Amelia Noviyanthi,Rosdiana Natzir,Khairuddin Djawad,Siswanto Wahab,Luh Made Mas Rusyati,Ressy Dwiyanti,Ade Rifka Junita, Azhar, Muhammad Reza Primaguna, Nur Indah Purnamasari,Ahmad Syukri, Ahmad Ezra Saleh,

    Background: Erythema nodosum leprosum (ENL) is an acute inflammatory complication of multibacillary leprosy. High-mobility group box 1 (HMGB1) mediates inflammatory signaling, whereas vascular endothelial growth factor (VEGF) regulates angiogenesis and vascular permeability. We compared whole-blood HMGB1 and VEGF messenger ribonucleic acid (mRNA) expression across leprosy groups and assessed their correlations. Methods: This cross-sectional study included 146 participants: 35 with ENL, 36 with multibacillary leprosy without ENL, 38 with paucibacillary leprosy, and 37 healthy controls. HMGB1 and VEGF mRNA expression was measured by one-step SYBR Green quantitative reverse-transcription polymerase chain reaction. Group differences were analyzed by one-way analysis of variance with Tukey post hoc testing, correlations by Pearson’s coefficient, and ENL versus multibacillary disease by multivariable linear regression adjusted for age, sex, bacterial index, and disease duration. Results: HMGB1 expression differed across groups (13.530, 12.478, 9.585, and 9.442; F[3,142] =1579.960; P < 0.001; η 2 = 0.971), as did VEGF (10.992, 9.885, 8.341, and 8.277; F[3,142] =656.570; P < 0.001; η 2 = 0.933). ENL showed the highest expression; multibacillary leprosy without ENL was intermediate, and paucibacillary leprosy did not differ from controls. After adjustment, ENL remained associated with higher HMGB1 (B = 1.223; 95% confidence interval [CI]: 0.907–1.539) and VEGF expression (B = 1.327; 95% CI: 0.991–1.662); both P < 0.001. HMGB1 and VEGF were strongly correlated within all groups ( r = 0.980–0.989; all P < 0.001). Conclusions: ENL was associated with the highest HMGB1 and VEGF mRNA expression. Their strong co-variation does not establish a direct HMGB1–VEGF pathway or diagnostic validity.

    2026
    引用
    AI阅读
    加入学术空间
    4Telomere Length Profile and Associated Clinical Factors among Tuberculosis Patients in Indonesia
    Fanny Fachrucha,Sita Andarini,Erlina Burhan,Heri Wibowo,Aria Kekalih, Moulid Hidayat, Rayhendra Hanif, Farhana Ibrahim Syuaib,Wiwien Heru Wiyono

    Background: Tuberculosis remains a major cause of chronic respiratory morbidity in developing countries, including Indonesia. Persistent lung injury in tuberculosis is driven by chronic inflammation and cellular senescence, biological processes closely linked to telomere shortening. However, data on telomere length (TL) profiles and their association with clinical factors in tuberculosis patients remain limited. To characterize TL profiles and identify associated clinical factors among tuberculosis patients in Indonesia. Methods: This cross-sectional study was conducted at Persahabatan National Respiratory Referral Hospital and Jakarta Islamic Hospital Cempaka Putih between October 2024 and March 2025. Adult patients with tuberculosis who met the inclusion criteria were enrolled. Relative telomere length (RTL) was measured from peripheral blood mononuclear cells using flow cytometry combined with fluorescence in situ hybridization. Results: A total of 64 tuberculosis patients were included, with a mean age of 41.36 ± 16.23 years, and the majority were male (68.7%). The mean RTL was 6.83 ± 1.36, with a median of 6.54. Shorter RTL was significantly associated with older age, higher body mass index (BMI), diabetes mellitus (DM), and the occurrence of drug-induced liver injury (DILI) ( P < 0.05). Among the evaluated clinical factors, age remained the strongest determinant of telomere shortening. Conclusions: RTL was shorter with increasing age, higher BMI, DM, and the occurrence of DILI in tuberculosis patients. These findings highlight telomere alteration as a potential clinical health indicator that may assist in identifying risk profiles in diagnostic and treatment contexts.

    2026
    引用
    AI阅读
    加入学术空间
    5Primary Drug Resistance Analysis of Mycobacterium Tuberculosis in Liupanshui, China
    Shunfu Yu, Ting Xu, Guangyou Yan, Hong Xiao, Shengxu Deng, Shaojing Fu, Honglin Liu

    Background: Drug-resistant tuberculosis (DR-TB) remains a major global public health challenge, while local drug resistance data in southwestern China are still incomplete. The drug resistance characteristics of Mycobacterium tuberculosis (MTB) in the Liupanshui area have not been systematically reported, and the clinical application value of the high-resolution melting (HRM) method for drug resistance detection in this region also lacks evaluation evidence. Methods: From February 2023 to September 2025, 1200 TB patients who attended designated TB treatment facilities in Liupanshui City were enrolled. The HRM method was used to detect resistance to isoniazid (INH), rifampicin (RFP), ethambutol (EMB), and fluoroquinolones (FQs). Meanwhile, among the culture-positive isolates ( n = 506), phenotypic drug susceptibility testing using the proportion method was performed for INH, RFP, EMB, levofloxacin (LVFX), and moxifloxacin (MOX). Univariate Chi-square tests and Cramer’s V coefficient were employed to assess associations between clinical variables and drug resistance, and multivariate logistic regression was used to identify independent influencing factors for resistance. All effect estimates were supplemented with 95% confidence intervals (CIs). The Bonferroni method was applied for multiple testing correction, with three independent multiple comparison scenarios established in this study, and the corrected significance levels (α’) were set at 0.0125, 0.01, and 0.0167, respectively. Results: Among the 1200 patients, 67.6% were male, and 86.1% were newly treated. The HRM method detected resistance rates of 12.8% (95% CI: 11.1%–14.8%) for INH, 13.1% (95% CI: 11.3%–15.1%) for RFP, 5.4% (95% CI: 4.3%–6.8%) for EMB, and 2.4% (95% CI: 1.7%–3.4%) for FQs. For the proportion method ( n = 506), the resistance rates were 15.6% (95% CI: 12.9%–19.2%) for INH, 17.2% (95% CI: 13.3%–19.7%) for RFP, 9.9% (95% CI: 7.6%–12.8%) for EMB, 3.4% (95% CI: 2.1%–5.3%) for LVFX, and 1.8% (95% CI: 0.9%–3.3%) for MOX. The overall prevalence of multidrugresistant TB (MDR-TB) in the study population was 8.0% (95% CI: 6.6%–9.7%), with 7.3% (95% CI: 5.8%–9.0%) in newly treated patients and 12.6% (95% CI: 8.4%–18.5%) in retreated patients. Agreement between the HRM method and the proportion method was excellent for INH and RFP (Kappa: 0.93 [95% CI: 0.89–0.97] and 0.95 [95% CI: 0.92–0.98], respectively), moderate for EMB (Kappa: 0.62 [95% CI: 0.54–0.70]), and good for FQs (Kappa: 0.82 [95% CI: 0.74–0.90]). The positive predictive values of the HRM method for INH and RFP were 97.3% and 93.1%, respectively, and the negative predictive values were 98.4% and 99.8%, indicating excellent diagnostic performance. Regularity of treatment was strongly correlated with genetic resistance to all four drugs ( P < 0.001, Cramer’s V coefficient: 0.115–0.632), and retreatment was significantly associated with RFP genetic resistance ( P < 0.001, Cramer’s V coefficient: 0.133). Multivariate logistic regression analysis showed that irregular treatment was an independent risk factor for RFP resistance (odds ratio = 59.94, 95% CI: 34.78–103.26, P < 0.001). Conclusion: The burden of DR-TB in Liupanshui area is substantial. The RFP resistance rate among newly treated patients (11.2%) exceeded the national baseline level for new cases. The prevalence of MDR-TB was relatively high, and retreated patients had a significantly elevated risk of resistance. The HRM method can serve as a rapid screening tool but should be complemented with phenotypic drug susceptibility testing for confirmation. Management of treatment adherence is a key element in controlling drug resistance. The findings of this study provide evidence-based support for the formulation of precise prevention and control strategies for TB in the Liupanshui area.

    2026
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 1459 篇论文

    高被引作者

    作者引用发文
    Ali Akbar Velayati51355
    Daniela Maria Cirillo40019
    Farnia Parissa39343
    Rumina Hasan36630
    Mehdi S. Mirsaeidi32112
    Trovato Alberto2475
    Dorothy Yeboah-Manu23312
    Enrico Tortoli2279
    Umesh Gupta2195
    Payam Tabarsi21032

    高产作者

    作者引用发文
    Ali Akbar Velayati51355
    Farnia Parissa39343
    Nader Mosavari10933
    Payam Tabarsi21032
    Rumina Hasan36630
    Majid Marjani12527
    Poopak Farnia15621
    Daniela Maria Cirillo40019
    Shakoor Sadia11318
    Sven Hoffner17518

    相关期刊

    Japanese journal of infectious diseases
    Le infezioni in medicina
    Indian Journal of Medical Microbiology
    The Indian journal of tuberculosis
    Interdisciplinary perspectives on infectious diseases
    Journal of clinical tuberculosis and other mycobacterial diseases
    Brazilian Journal of Infectious Diseases
    Revista do Instituto de Medicina Tropical de Sao Paulo
    GERMS
    Mikrobiyoloji Bulteni